Novartis touts new T-cell therapy data in race for FDA approval Ruby Khatun Khatun9 Jun 2017 11:29 AM ISTZURICH: Novartis on Wednesday touted new data from its T-cell therapy CTL019, saying it is on a par with results of experimental molecules from Kite...
Gufic Biosciences gets two patent certificates; stock soars over 5% Ruby Khatun Khatun9 Jun 2017 11:29 AM ISTMumbai: Gufic Biosciences on Monday informed the bourses that it has received two patent certificates from the Intellectual Property India, The Patent...
Unichem lines up Rs 350 crore capex for next two years Ruby Khatun Khatun9 Jun 2017 11:28 AM ISTNew Delhi: Drug firm Unichem Laboratories has lined up a capex of around Rs 350 crore for the next two years as it plans to strengthen R&D...
Strides Shasun Gets USFDA Approval For Parkinsons Drug Ruby Khatun Khatun9 Jun 2017 11:28 AM ISTNew Delhi: Strides Shasun said it has received approval from the US health regulator for Amantadine Hydrochloride, used for the treatment of...
South Korea to fine Novartis unit over unfair drug promotions Ruby Khatun Khatun9 Jun 2017 10:24 AM ISTSouth Korea's antitrust regulator said it would fine Novartis' local unit 500 million won ($444,089) for alleged unfair promotions, in another setback...
Zydus Cadila gets USFDA nod for mesalamine tablets Ruby Khatun Khatun8 Jun 2017 2:24 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received the US health regulator's nod to market mesalamine tablets, used for the treatment of...
Teva's migraine drug clears another hurdle, aims for launch in 2018 Ruby Khatun Khatun8 Jun 2017 1:27 PM ISTTeva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraines cleared another late-stage study, setting it on course...
Telangana Medical Devices Park to be launched on June 17 Ruby Khatun Khatun8 Jun 2017 1:27 PM IST'Telangana Medical Devices Park', a dedicated ecosystem for MedTech innovation and manufacturing will be launched at Sultanpur village in Medak...
AstraZeneca sells migraine drug for up to 302 million dollar Ruby Khatun Khatun8 Jun 2017 1:23 PM ISTAstraZeneca continued its program of divesting old medicines on Wednesday with the sale for up to $302 million of migraine drug Zomig to Germany's...
AbbVie's rheumatoid arthritis drug succeeds in trial Ruby Khatun Khatun8 Jun 2017 9:27 AM ISTAbbVie Inc said on Wednesday its oral rheumatoid arthritis drug succeeded in a late-stage study on patients who had not adequately responded to...
Alembic Pharma looks to file 100 ANDAs in US in next 3 yrs Ruby Khatun Khatun7 Jun 2017 1:33 PM ISTDrug firm Alembic Pharmaceuticals is looking at filing 100 abbreviated new drug applications with the US health regulator over the next three years...
Dr Reddy's Laboratories Announces Launch of Bivalirudin for Injection in US Market Ruby Khatun Khatun7 Jun 2017 1:32 PM ISTHyderabad & Princeton: Dr. Reddy’s Laboratories Ltd. announced that it has launched Bivalirudin for Injection, 250 mg/vial, a therapeutic...
